Indefinite Delivery Contract SPE2DP24D0003
Award Date
11/14/23
Last Date to Order
11/13/24
Federal Agency
Medical Supply Chain
Awardee
Sanofi Pasteur Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The 5-year contract, valued at up to $4,023,280.80, is for the provision of Influenza Virus Vaccines in support of public health preparedness missions. Sanofi Pasteur holds multiple IDVs with various federal agencies, including the Department of Health and Human Services, Centers for Disease Control and Prevention, and...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $82,229,910.30 contract provides seasonal and pre-pandemic influenza vaccines, as well as other standard immunizations, to support disease prevention and public health preparedness for federal agencies. The IDC is a multiple award vehicle with a ceiling value of $82,229,910.30 and a period of...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $640,309,577 multiple-award contract, identified as VFA 2009, has an ultimate completion date of June 30, 2010. Under this IDC, Sanofi Pasteur Inc. is the prime contractor responsible for providing a range of vaccine products and services to support various federal...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and medical goods. The $26.5 million single-award IDC, awarded on March 15, 2010 with a final completion date of February 28, 2011, provides for the delivery of a variety of vaccine products and related services to support the CDC's public health preparedness and...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract, valued at a ceiling of $669,123,533.05, is for the provision of various vaccine products and related services to support public health missions across multiple federal agencies. The scope of the IDC includes seasonal and pre-pandemic influenza vaccines,...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies. The contract, valued at $163,144,080.00, is for the procurement of pediatric flu vaccines for the 2025-2026 fiscal year. The IDC is a multiple-award vehicle that will allow the CDC to issue task orders for the delivery of the required vaccines over the contract's period of...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide adult flu vaccines for the 2024-2025 season. The contract has a ceiling value of $64,529,958.50 and a period of performance through February 28, 2025. As the prime contractor, Sanofi Pasteur Inc. will leverage its pharmaceutical manufacturing and distribution capabilities to efficiently fulfill CDC's requirements for seasonal influenza vaccines to...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Sanofi Pasteur Inc., the prime contractor. The contract has a total ceiling value of $158,256,000 and a period of performance running through February 28, 2025. The purpose of this IDC is to provide pediatric influenza vaccines to the CDC for the 2024-2025 season. Sanofi Pasteur, as a manufacturer of vaccines and pharmaceutical products, will fulfill task...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc. as the prime contractor. The contract has a ceiling value of $1,219,916,713.60 and a period of performance through January 31, 2011. Under this IDC, Sanofi Pasteur Inc. is providing a range of vaccine products and services to support disease prevention and maintain public health preparedness for federal agencies including the Department...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The contract has a ceiling value of $54,894,803.20 and a period of performance from July 1, 2025, to June 30, 2026. The contract is intended to procure a variety of adult vaccines, including seasonal and pandemic influenza vaccines, respiratory syncytial virus...